Brief: Mymd Pharmaceuticals Announces Positive Clinical Data In Advance Of Upcoming Phase 2 Trial Of Mymd-1 For Extending Healthy Lifespan

Q/C Technologies

08/02/2022 14:24

Feb 8 (Reuters) - MyMD Pharmaceuticals Inc  MYMD.O :
    * MYMD PHARMACEUTICALS ANNOUNCES POSITIVE CLINICAL DATA IN
ADVANCE
OF UPCOMING PHASE 2 TRIAL OF MYMD-1 FOR EXTENDING HEALTHY
LIFESPAN
    * MYMD PHARMACEUTICALS INC - PHASE 1 DOSE-RANGING STUDY
RESULTS
MEET PRIMARY ENDPOINTS
    * MYMD PHARMACEUTICALS INC - DRUG DEMONSTRATES STATISTICALLY
SIGNIFICANT EFFICACY IN REDUCING LEVELS OF ROOT CAUSE OF AGING,
TNF-Α, IN BLOOD
    * MYMD PHARMACEUTICALS INC - DATA FROM FULLY FUNDED PHASE 2
TRIAL
ANTICIPATED IN FIRST HALF OF 2022

Source text for Eikon:  ID:nBw9mvpX3a 
Further company coverage:  MYMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))